Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans
- 13 January 2003
- journal article
- Published by Wiley in Journal of Medical Virology
- Vol. 69 (3), 426-440
- https://doi.org/10.1002/jmv.10306
Abstract
Molecular mimicry is one of the mechanisms by which enterovirus infections have been postulated to have a role in the pathogenesis of type 1 diabetes. Immunogenic epitopes in enterovirus capsid protein VP1 and procapsid protein VP0 have sequence similarities with diabetes‐associated epitopes in tyrosine phosphatase IA‐2/IAR and heat shock protein 60. In the present study, documented enterovirus infection was shown to induce humoral responses, that in 7% and 1% of patients cross‐reacted with the known diabetes‐associated epitopes in tyrosine phosphatase IAR and heat shock protein 60, respectively. In contrast, none of the children vaccinated against poliomyelitis had antibodies to the diabetes‐associated epitope of tyrosine phosphatases IA‐2/IAR. The antibody response studied in serum samples from six patients with coxsackievirus A9 infection was mainly targeted to capsid protein VP1. Coxsackievirus A9 infection induced antibodies cross‐reacted with one epitope in heat shock protein 60, but not with epitopes derived from other autoantigens. Most diabetic children had high levels of antibodies to both coxsackievirus and poliovirus derived VP1 peptides but the pattern of reactivity did not differ from that seen in healthy children. The reactivity of linear epitopes derived from autoantigens was low in general and associated with the presence of multiple autoantibodies in the patients. Some linear auto‐epitopes derived from tyrosine phosphatase IA‐2, glutamic acid decarboxylase 65, preproinsulin, and heat shock protein 60 were recognized by sera from diabetic patients, but not by sera from healthy children. In conclusion, enteroviruses may induce immune responses that react with islet cell autoantigens, which is a concern when a putative inactivated enterovirus vaccine is considered. J. Med. Virol. 69:426–440, 2003.Keywords
Funding Information
- Academy of Finland
- Sigrid Juselius Foundation, Helsinki, Finland
- Finnish Diabetes Research Foundation
- Juvenile Diabetes Research Foundation
This publication has 44 references indexed in Scilit:
- Coxsackievirus immunization delays onset of diabetes in non‐obese diabetic miceJournal of Medical Virology, 2003
- Persistent Infection of Human Pancreatic Islets by Coxsackievirus B Is Associated with Alpha Interferon Synthesis in β CellsJournal of Virology, 2000
- Increased Level of Interferon‐α in Blood of Patients with Insulin‐Dependent Diabetes Mellitus: Relationship with Coxsackievirus B InfectionThe Journal of Infectious Diseases, 2000
- T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulinProceedings of the National Academy of Sciences, 1998
- A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model.Proceedings of the National Academy of Sciences, 1996
- Maternal Enteroviral Infection During Pregnancy as a Risk Factor for ChildHood IDDM: A Population-Based Case-Control StudyDiabetes, 1995
- The Pathogenesis of Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1994
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Antibodies to a Mr-64000 islet cell protein in Swedish children with newly diagnosed Type 1 (insulin-dependent) diabetesDiabetologia, 1988
- COXSACKIE B, MUMPS, RUBELLA, AND CYTOMEGALOVIRUS SPECIFIC IgM RESPONSES IN PATIENTS WITH JUVENILE-ONSET INSULIN-DEPENDENT DIABETES MELLITUS IN BRITAIN, AUSTRIA, AND AUSTRALIAThe Lancet, 1985